Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients.

MLA

Mao, Yuqiang, et al. “Elevated Fibrous Sheath Interacting Protein 1 Levels Are Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients.” Oncotarget, vol. 8, no. 7, Feb. 2017, pp. 12186–93. EBSCOhost, https://doi.org/10.18632/oncotarget.14575.

APA

Mao, Y., Xu, R., Liu, X., Shi, W., & Han, Y. (2017). Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients. Oncotarget, 8(7), 12186–12193. https://doi.org/10.18632/oncotarget.14575

Chicago

Mao, Yuqiang, Ran Xu, Xiaoying Liu, Wenjun Shi, and Yun Han. 2017. “Elevated Fibrous Sheath Interacting Protein 1 Levels Are Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients.” Oncotarget 8 (7): 12186–93. doi:10.18632/oncotarget.14575.